New - European Medical Journal

Continue

News

EMJ
Innovations
24 Nov 2015

Frost & Sullivan Award to Ebit (Esaote Group) for Suitestensa Technically Advanced Cardiovascular Information System Integration Platform – CVIS PACS

Genoa, 18 November 2015 – Frost & Sullivan, a global organization collaborating with international companies to leverage innovation and…
EMJ
Cardiology
24 Nov 2015

SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms

SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
EMJ
Urology
23 Nov 2015

International Guidelines for Detecting Prostate Cancer with MRI Scans

GLOBAL guidelines introducing a new standard for how MRI images are evaluated to diagnose prostate cancer promise to reduce the number of cases of…
EMJ
Urology
23 Nov 2015

Effective Treatment of Urinary Infections Using DNA Sequencing

NOVEL DNA sequencing device has been identified as a potential tool to increase the speed and efficacy of the treatment of urinary tract infections (UTIs).
EMJ
Neurology
20 Nov 2015

Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer

Nottingham, UK – 19 November 2015: Oncimmune, a leader in early cancer detection, today announced the appointment of Dr James Jett, as Chief Medical…
EMJ
Dermatology
20 Nov 2015

Safety and Efficacy Multicentre Study of a New Multifocal Treatment to Control Acne-Prone Skin

OBJECTIVE: Assess the effectiveness and safety of a new multifocal topical method (acnelan) for acne-prone skin, using in-vitro and in-vivo studies.
EMJ
Rheumatology
19 Nov 2015

Two New Analyses Show Cost Effectiveness of Rifaximin-α 550mg Treatment in Belgian and Dutch Patients with Recurrent Hepatic Encephalopathy

LONDON, UK, Thursday 19 November, 07.00 GMT: Norgine B.V. has presented new analyses demonstrating the cost effectiveness of XIFAXAN® / TARGAXAN® 550…
EMJ
Urology
17 Nov 2015

Study Shows Prostate Cancer Screening under Age of 55 May be of Limited Value

Barcelona, 14 November 2015: Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after…